In children with achondroplasia in real-world settings, vosoritide treatment over 12 months demonstrated a positive benefit-risk profile consistent with data from clinical trials, according to a study ...

Achondroplasia is one of the most frequent bone disorders that prevents bone growth especially in the arms and legs, resulting in very severe short stature with average height for males and females ...